Last reviewed · How we verify
NCT06290076
A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy
trial in Acute Ischemic Stroke in 1,500 participants. Completed in 30 September 2023.
30 June 2023
Quick facts
| Lead sponsor | Xuanwu Hospital, Beijing |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 1 January 2020 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across China |
Conditions studied
- Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →
- Endovascular Thrombectomy — all drugs for Endovascular Thrombectomy →
- Symptomatic Intracranial Hemorrhage — all drugs for Symptomatic Intracranial Hemorrhage →
- Malignant Cerebral Edema — all drugs for Malignant Cerebral Edema →
Sponsor
Xuanwu Hospital, Beijing
Who can join
18 and older, any sex, with Acute Ischemic Stroke or Endovascular Thrombectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To establish a predictive model and scoring system for predicting severe complications after thrombectomy. This scoring system can be used to identify high-risk patients after endovascular thrombectomy, guide the early use of adjunctive interventions, and provide reference for future clinical trials.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Predictive factors for very poor outcomes after endovascular thrombectomy in anterior circulation large vessel occlusion: a multicentre retrospective study in China.
Li Z, Hao J, Wen C, Cheng T, et al · · 2025 · PMID 41130675 · DOI 10.1136/bmjopen-2025-101244
Verify or expand the search:
- PubMed search for NCT06290076
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Ischemic Stroke
Currently open trials in the same condition.
- NCT07115940 — Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours · NA · recruiting
- NCT07404852 — Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemi · NA · recruiting
- NCT07361302 — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe · Phase 3 · recruiting
- NCT07436156 — SUMMIT RISE Study of Acute Ischemic Stroke Patients · Phase 4 · recruiting
- NCT07203625 — Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours · Phase 4 · recruiting
Other Xuanwu Hospital, Beijing trials
Trials by the same sponsor.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07519044 — Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion · Phase 4 · not yet recruiting
- NCT07396077 — Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II · NA · not yet recruiting
- NCT07457125 — The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease · Phase 1, PHASE2 · not yet recruiting
- NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06290076 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xuanwu Hospital, Beijing
- Last refreshed: 4 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06290076.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing